$250 | Single User
$500 | Site License
$750 | Global License

ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

Published by Global Data: 23 Oct 2018 | 226177 | In Stock

Introduction

Summary

ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered complement inhibitor of the complement C5a receptor (C5aR), for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CCX872, an orally administered inhibitor for pancreatic cancer; and CCX140, an orally-administered inhibitor of the chemokine receptor known for patients with diabetic nephropathy, among others. It also carries out preclinical research for evaluating the effect of combination therapy with chemokine receptor and check point inhibitors. ChemoCentryx is headquartered in Mountain View, California, the US.

ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    ChemoCentryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

    ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deal Details 10

    Venture Financing 10

    ChemoCentryx to Raise USD50 Million in Financing 10

    Licensing Agreements 11

    Vifor Pharma Enters into Licensing Agreement with ChemoCentryx 11

    Vifor Pharma Expands Licensing Agreement with ChemoCentryx for CCX168 12

    Equity Offering 13

    ChemoCentryx Withdraws Public Offering of Shares for USD75 Million 13

    ChemoCentryx Completes Public Offering Of Common Stock For US Million 15

    ChemoCentryx Raises USD7 million in Private Placement of Shares 16

    ChemoCentryx Completes IPO Of Common Stock For US Million 17

    ChemoCentryx Completes Private Placement Of Shares For US Million 19

    Acquisition 20

    Vifor Pharma to Acquire 14.6% Stake in Chemocentryx from GlaxoSmithKline 20

    ChemoCentryx Inc - Key Competitors 22

    ChemoCentryx Inc - Key Employees 23

    ChemoCentryx Inc - Locations And Subsidiaries 24

    Head Office 24

    Other Locations & Subsidiaries 24

    Recent Developments 25

    Financial Announcements 25

    Aug 09, 2018: Chemocentryx reports second quarter 2018 financial results and recent highlights 25

    May 09, 2018: ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights 27

    Mar 09, 2018: ChemoCentryx Reports Fourth Quarter And Full Year 2017 Financial Results And Recent Highlights 28

    Nov 07, 2017: ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights 30

    Aug 08, 2017: ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights 31

    May 10, 2017: ChemoCentryx Reports First Quarter 2017 Financial Results 32

    Mar 14, 2017: ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results 33

    Corporate Communications 34

    Jan 08, 2018: ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer 34

    Appendix 35

    Methodology 35

    About GlobalData 35

    Contact Us 35

    Disclaimer 35

List Of Tables
in ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

List of Tables

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ChemoCentryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ChemoCentryx Inc, Deals By Therapy Area, 2012 to YTD 2018 8

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

ChemoCentryx to Raise USD50 Million in Financing 10

Vifor Pharma Enters into Licensing Agreement with ChemoCentryx 11

Vifor Pharma Expands Licensing Agreement with ChemoCentryx for CCX168 12

ChemoCentryx Withdraws Public Offering of Shares for USD75 Million 13

ChemoCentryx Completes Public Offering Of Common Stock For US Million 15

ChemoCentryx Raises USD7 million in Private Placement of Shares 16

ChemoCentryx Completes IPO Of Common Stock For US Million 17

ChemoCentryx Completes Private Placement Of Shares For US Million 19

Vifor Pharma to Acquire 14.6% Stake in Chemocentryx from GlaxoSmithKline 20

ChemoCentryx Inc, Key Competitors 22

ChemoCentryx Inc, Key Employees 23

ChemoCentryx Inc, Subsidiaries 24

List Of Figures, Charts and Diagrams
in ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

List of Figures

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

ChemoCentryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

226177 | GDPH140080D

Number of Pages

35

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemoCentryx Inc (ChemoCentryx) discovers, develops and commercializes orally-administered th...
23 Feb 2017 by Global Data USD $250 More Info
ChemoCentryx Inc (CCXI) - Financial and Strategic SWOT Analysis Review
SummaryChemoCentryx Inc (ChemoCentryx) discovers, develops and commercializes orally-administered th...
13 Jan 2017 by Global Data USD $300 More Info
ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemoCentryx Inc (ChemoCentryx) discovers, develops and commercializes orally-administered th...
24 Nov 2016 by Global Data USD $250 More Info
ChemoCentryx, Inc. (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that discovers, develops and...
24 Aug 2016 by Global Data USD $250 More Info
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
11 Jul 2016 by Global Data USD $300 More Info
ChemoCentryx, Inc. (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
06 May 2016 by Global Data USD $250 More Info
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
15 Apr 2016 by Global Data USD $300 More Info
ChemoCentryx, Inc. (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
10 Mar 2016 by Global Data USD $250 More Info
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
09 Jan 2016 by Global Data USD $300 More Info
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review
SummaryChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company that develops therapies. The...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

ChemoCentryx Inc (CCXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data